Is Pfizer A Good Stock To Buy -

To help you decide if Pfizer aligns with your portfolio, we’ve broken down the current financial health, growth drivers, and risks based on recent market data and analyst consensus.

: Following its $43 billion acquisition of Seagen, Pfizer is now a powerhouse in oncology. Cancer-fighting drugs now account for roughly 27% of total revenue , with the company aiming for eight blockbuster oncology medicines by 2030. is pfizer a good stock to buy

For many, the primary reason to hold Pfizer is its status as a premier income stock. To help you decide if Pfizer aligns with

: The stock is currently trading at a forward price-to-earnings (P/E) ratio of roughly 9.3x to 9.4x . This is well below its five-year mean and significantly cheaper than industry peers like Eli Lilly or Novo Nordisk. For many, the primary reason to hold Pfizer

: As of late April 2026, Pfizer offers a robust forward dividend yield of approximately 6.3% to 6.4% . This significantly outpaces the broader pharmaceutical sector average.